Vanguard Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$663K Hold
26,450
– – ﹤0.01% 2060
2026
Q2
$671K Hold
26,450
– – ﹤0.01% 2070
2026
Q1
$598K Buy
+26,450
New +$588K ﹤0.01% 2009

Other funds holding PCRX

Vanguard Asset Management's PCRX Position: Q3 2026 in Review

Vanguard Asset Management held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 26,450 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Vanguard Asset Management first reported a position in PCRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $671K in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Vanguard Asset Management held 26,450 shares of Pacira BioSciences worth $663K as of Q3 2026.
  • Vanguard Asset Management left its Pacira BioSciences share count unchanged in Q3 2026.
  • Pacira BioSciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2060 holding.
  • Vanguard Asset Management first reported a position in Pacira BioSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Pacira BioSciences position peaked at $671K in Q2 2026.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.